In all industries, events happen that change the course of how product is manufactured, moved or shipped. These changes may be dictated by market requirements, government regulations or changes in the supply network.
In the case of life sciences, a number of state and international mandates require companies to serialize and identify product at the saleable-unit level, so that prescription drugs can be effectively tracked and traced through the supply chain. And to do so, companies have a number of solutions available to them.
In this program, two of the industry's leading experts - Gartner Vice President Steven LeFebure and Acsis, Inc. CTO John DiPalo - reveal how companies can get the maximum business benefit out of a serialization solution.